Ling Ding
机构：Shanxi Medical University · ORCID：0000-0002-1163-4848
发表论文 67 篇 · 总被引 220 次 · h-index 8
代表论文
- Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy (2024 · Cancer Letters · 被引 39)
- Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1 (2024 · Advanced Science · 被引 15)
- Selective BCL-2 inhibitor triggers STING-dependent antitumor immunity via inducing mtDNA release (2025 · Journal for ImmunoTherapy of Cancer · 被引 8)
- Figure S6 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)
- Figure S4 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)
- cohort1-47 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)